Literature DB >> 29981103

Awareness of, interest in, and willingness to pay for HIV pre-exposure prophylaxis among Canadian gay, bisexual, and other men who have sex with men.

Jeffrey Morgan1, Olivier Ferlatte2, Travis Salway3, James Wilton4, Mark Hull5.   

Abstract

OBJECTIVES: Pre-exposure prophylaxis (PrEP) is a highly effective, HIV prevention strategy increasingly being accessed by gay, bisexual, and other men who have sex with men (GBMSM). GBMSM face structural and individual-level barriers accessing PrEP, including awareness and cost. This paper assesses socio-demographic factors associated with awareness, interest, and willingness to pay for PrEP in a sample of Canadian GBMSM.
METHODS: Data were derived from the 2015 Sex Now survey, a cross-sectional, online survey of GBMSM. Respondents were recruited through social media, sex-seeking "apps," and by word of mouth. We used univariable and multivariable logistic regression models to estimate associations between socio-demographic factors and three primary outcomes.
RESULTS: Our sample consisted of 7176 HIV-negative Canadian GBMSM. Of respondents, 54.7% were aware of PrEP, 47.4% were interested in PrEP, and 27.9% of PrEP-interested respondents reported they would pay for PrEP out-of-pocket. Awareness and interest varied between provinces, while GBMSM outside urban areas were less likely to be PrEP aware. Bisexual-identified men, and men over 50, were less likely to be aware and interested in PrEP in multivariable models. Only annual income and educational attainment were associated with willingness to pay for PrEP.
CONCLUSION: This study identifies important disparities in awareness, interest, and willingness to pay for PrEP. Future interventions and educational efforts should target non-gay-identified and older GBMSM, as well as GBMSM outside urban areas. PrEP implementation may risk further perpetuating existing health inequities based on socio-economic status if PrEP continues to be accessed primarily through private insurance or paid for out-of-pocket.

Entities:  

Keywords:  Canada; Human immunodeficiency virus (HIV); Men who have sex with men; Pre-exposure prophylaxis (PrEP)

Mesh:

Year:  2018        PMID: 29981103     DOI: 10.17269/s41997-018-0090-1

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  7 in total

Review 1.  Update on HIV Preexposure Prophylaxis: Effectiveness, Drug Resistance, and Risk Compensation.

Authors:  Victoria E Powell; Kevin M Gibas; Joshua DuBow; Douglas S Krakower
Journal:  Curr Infect Dis Rep       Date:  2019-06-21       Impact factor: 3.725

2.  Interest In and Uptake of HIV Pre-Exposure Prophylaxis (PrEP): A Cross-Sectional Study of High-Risk Patients in Western Canada.

Authors:  Stanley Enebeli; Udoka Okpalauwaekwe; Prosanta K Mondal; Johnmark Opondo; Anne Leis
Journal:  Cureus       Date:  2022-04-19

3.  Eliciting Preferences for HIV Prevention Technologies: A Systematic Review.

Authors:  S Wilson Beckham; Norah L Crossnohere; Margaret Gross; John F P Bridges
Journal:  Patient       Date:  2020-12-15       Impact factor: 3.883

4.  Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation.

Authors:  Mark Gaspar; Travis Salway; Daniel Grace
Journal:  Soc Theory Health       Date:  2021-01-14

5.  "It's a win for the clinic, it's a win for the frontline, but, most importantly, it's a win for the client": Task Shifting HIV Prevention Services from Clinicians to Community Health Workers in Ontario, Canada.

Authors:  David J Brennan; Maxime Charest; Aaron Turpin; Dane Griffiths; Barry D Adam; John Maxwell; Keith McCrady; Robbie Ahmed
Journal:  Sex Res Social Policy       Date:  2022-04-28

6.  Canadian results from the European Men-who-have-sex-with-men Internet survey (EMIS-2017).

Authors:  N Brogan; D M Paquette; N J Lachowsky; M Blais; D J Brennan; T A Hart; B Adam
Journal:  Can Commun Dis Rep       Date:  2019-11-07

7.  Strategies to support HIV literacy in the roll-out of pre-exposure prophylaxis in Scotland: findings from qualitative research with clinical and community practitioners.

Authors:  Ingrid Young; George Valiotis
Journal:  BMJ Open       Date:  2020-04-28       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.